Back to search
FDAFDA · Food and drugs·Recall number D-1440-2016

Daytrana (methylphenidate transdermal system) Transdermal Patch, 30 mg over 9 hours (3.3 mg/hr), packaged in 30-count patches per box, Rx only, Manufactured by Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC 68968-5555-3.

Published July 20, 2016 · Recall initiated: December 21, 2015

Summary

FDA records drug Class II recall D-1440-2016, published July 20, 2016 and initiated December 21, 2015. Recalling firm: Noven Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 12285 boxes; Lot: Lot #s: 77379, 77380, Exp 05/16; 76944, Exp 03/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration.

What to do

Voluntary: Firm initiated · Letter

Get an email if DAYTRANA has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DAYTRANA
Manufacturer
Noven Pharmaceuticals, Inc.
Distributor
Nationwide
Lot
Lot #s: 77379, 77380, Exp 05/16; 76944, Exp 03/16
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Daytrana (methylphenidate transdermal system) Transdermal Patch, 30 mg over 9 hours (3.3 mg/hr), packaged in 30-count patches per box, Rx only, Manufactured by Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC 68968-5555-3. recalled?

Yes. FDA published recall D-1440-2016 on July 20, 2016. Reported hazard: Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DAYTRANA.